MedElevator Войти в исследования
← Поиск публикаций

DOI 10.53854/liim-3003-3

Медицинская библиотека · Le infezioni in medicina · 2022

MIS-C related to SARS-CoV-2 infection: a narrative review of presentation, differential diagnosis, and management.

Gadiwala Salika, Mistry Ayushi, Patel Sejal, Chaithanya Avanthika, Pathak Stuti, Satnarine Travis, Bekina-Sreenivasan Daria, Bakarr Abdul Akim, Das Bibhuti Bhusan, Chakinala Raja Chandra, Patel Saurabhkumar, Areti Sathya

СтатьяОбзорПеревод в очереди

Аннотация

Multisystem Inflammatory Syndrome in Children (MIS-C), a rare condition, has been reported approximately 2-4 weeks after the onset of COVID-19 in children and adolescents, causing inflammation in multiple systems, including cardiovascular and respiratory, digestive, and central nervous systems. This condition is also known as hyperinflammatory shock, Kawasaki-like disease, and Pediatric Inflammatory Multisystem Syndrome (PIMS). The signs and symptoms include but are not limited to fever, rash, peripheral edema, gastrointestinal symptoms, conjunctivitis, and shock. Thirty-eight studies met our criteria, with a total of 5822 patients. The most affected population was between 5-18 years of age. We noted that MIS-C presented with a wide range of signs and symptoms that overlap with Kawasaki Disease, including high fever, sore throat, malaise, tachypnea, tachycardia, conjunctival injection, mucosal edema, cardiac involvement, and gastrointestinal symptoms. It causes an increase in IL-17A, IL-6, and arterial damage, a distinct difference from Kawasaki disease. The laboratory findings in MIS-C showed an increase in inflammatory markers like CRP, ESR, ferritin, leukocytes, and TNF-α. WHO stated that 23% of affected children with MIS-C had underlying conditions like chronic lung diseases, cardiovascular disease, and immunosuppression. In most affected children, aspirin and IVIG were successful, which resulted in a decrease in the inflammatory markers. We find that MIS-C is a rare, but potentially fatal pediatric complication, after COVID-19 infection. The aim of this article is to study the emerging relationship between COVID-19 and MIS-C in children and adolescents affected by this condition, to discuss the immunological mechanisms, and explore potential therapies.

Для цитирования: Gadiwala Salika, Mistry Ayushi, Patel Sejal, Chaithanya Avanthika, Pathak Stuti, Satnarine Travis, Bekina-Sreenivasan Daria, Bakarr Abdul Akim, Das Bibhuti Bhusan, Chakinala Raja Chandra, Patel Saurabhkumar, Areti Sathya. MIS-C related to SARS-CoV-2 infection: a narrative review of presentation, differential diagnosis, and management.. Le infezioni in medicina. 2022. DOI: 10.53854/liim-3003-3.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.